Home > News > Nanogen Reports 2003 Fourth Quarter and Year-End
February 18th, 2004
Nanogen Reports 2003 Fourth Quarter and Year-End
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular diagnostic products, today announced its financial results for the fourth quarter and year ended December 31, 2003. Total revenues for the quarter ended December 31, 2003 were $2.1 million compared to $1.7 million in the third quarter of 2003 and $12.1 million in the fourth quarter of 2002. Fourth quarter product revenue increased by 45% over the prior quarter on the basis of eight new instrument sales and one reagent rental.
Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal 2014 Earnings Release and Conference Call for February 26, 2015 February 11th, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015